Latest News and Press Releases
Want to stay updated on the latest news?
-
BOISE, Idaho, March 03, 2022 (GLOBE NEWSWIRE) -- Healthwise, a leader in evidence-based health education, today announced an expanded collaboration with FDB (First Databank, Inc.), the leading...
-
LAKEWOOD RANCH, Fla., March 03, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Piezo Motion, a Brain Scientific (OTCQB:BRSF) company, will host a webinar on March 17 discussing how its miniature...
-
Clinical data from multiple novel, PN-modified stereopure oligonucleotides for ALS/FTD, DMD, and HD expected in 2022 GalNAc-AIMers restore therapeutically relevant levels of AAT for lung...
-
New York, March 03, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Compression Therapy Global Market Report 2022" -...
-
Dublin, March 03, 2022 (GLOBE NEWSWIRE) -- The "IoT Real Time Operating Systems (RTOS) Market by Components, Processor Type, OS, Segment, and Industry Verticals 2022 - 2027" report has been added to...
-
New York, March 03, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cleanroom Robots In Healthcare Market Size, Share & Trends Analysis Report By Type, By...
-
VANCOUVER, British Columbia, March 03, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”), is pleased to announce that...
-
SALT LAKE CITY, March 02, 2022 (GLOBE NEWSWIRE) -- Paul J. Diaz, president and CEO of Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will be participating...
-
NDA for VP-102 for the treatment of molluscum assigned a PDUFA date of May 24, 2022 Company expects to dose first patient in Phase 2 trial of LTX-315 in basal cell carcinoma in the first quarter of...
-
Thanks to the AGIR program, DEINOVE has become a unique French industrial biotech in the fight against antibiotic resistance The AGIR program, supported by the Investments for the Future Program,...